Verisk Analytics recently discussed the evolving cannabis landscape in a webinar, noting that while recreational cannabis is legal in 24 states and D.C., litigation around product potency is on the rise, with claims related to mislabeling and THC content. The growth of hemp-derived products like delta-8 THC also raises questions, as emerging substances such as kratom and psychedelics draw attention in the legal arena. Insurance professionals must navigate these complexities as the market evolves. Source and details of the news